Published in Nat Commun on January 01, 2012
Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. FASEB J (2013) 2.12
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest (2014) 2.06
Adult-specific functions of animal microRNAs. Nat Rev Genet (2013) 1.89
Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization. J Am Coll Cardiol (2015) 1.46
Autophagy: regulation and role in development. Autophagy (2013) 1.28
The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS One (2014) 1.22
Autophagy in cardiovascular biology. J Clin Invest (2015) 1.14
Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol (2013) 1.11
Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction. Biomed Res Int (2014) 1.07
Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts. Cell Death Dis (2015) 1.07
miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS One (2013) 1.06
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol (2015) 1.04
Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta (2014) 1.04
Retracted A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J Biol Chem (2013) 1.00
"Zebrafishing" for novel genes relevant to the glomerular filtration barrier. Biomed Res Int (2013) 0.98
Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol (2014) 0.96
The MicroRNA-132 and MicroRNA-212 Cluster Regulates Hematopoietic Stem Cell Maintenance and Survival with Age by Buffering FOXO3 Expression. Immunity (2015) 0.94
Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease. Cells (2014) 0.94
MicroRNA control of high-density lipoprotein metabolism and function. Circ Res (2014) 0.93
Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol (2015) 0.92
miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS One (2014) 0.90
Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration. Int J Mol Sci (2014) 0.89
Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization. Antioxid Redox Signal (2013) 0.88
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death. Cell Death Dis (2014) 0.88
miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21. J Cell Mol Med (2015) 0.86
Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J Cell Mol Med (2014) 0.86
Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts. Sci Rep (2016) 0.86
Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4. Mol Cancer (2015) 0.85
Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy. J Cell Mol Med (2015) 0.85
MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1. J Cell Mol Med (2014) 0.84
MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ (2014) 0.84
Mitochondrial autophagy--an essential quality control mechanism for myocardial homeostasis. Circ J (2013) 0.84
MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest (2015) 0.83
Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells. PLoS One (2015) 0.82
MicroRNA-mediated autophagic signaling networks and cancer chemoresistance. Cancer Biother Radiopharm (2013) 0.82
MicroRNAs in heart failure: Small molecules with major impact. Glob Cardiol Sci Pract (2014) 0.82
MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts. Genes Immun (2014) 0.82
miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet (2015) 0.82
Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure. Circ Res (2015) 0.82
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease. Genes Dis (2014) 0.81
MicroRNA: A new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc Med (2016) 0.81
Role of cell death in the progression of heart failure. Heart Fail Rev (2016) 0.81
Functions of autophagy in pathological cardiac hypertrophy. Int J Biol Sci (2015) 0.81
MicroRNA Mechanisms of Action: What have We Learned from Mice? Front Genet (2015) 0.80
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis. Int J Mol Sci (2016) 0.80
MicroRNA Therapeutics: the Next Magic Bullet? Mini Rev Med Chem (2015) 0.80
MicroRNAs and Drug Addiction. Front Genet (2013) 0.80
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence. Oncotarget (2015) 0.80
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy. Nat Commun (2016) 0.79
MicroRNAs in the Stressed Heart: Sorting the Signal from the Noise. Cells (2014) 0.79
MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far. Biomed Res Int (2015) 0.79
Detrusor induction of miR-132/212 following bladder outlet obstruction: association with MeCP2 repression and cell viability. PLoS One (2015) 0.79
Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs. Circ Cardiovasc Genet (2015) 0.78
Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis? Mol Ther (2015) 0.78
In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging. Eur J Nucl Med Mol Imaging (2014) 0.78
Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy. J Clin Invest (2014) 0.78
The role of autophagy in cardiac hypertrophy. Acta Biochim Biophys Sin (Shanghai) (2016) 0.78
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy. Sci Rep (2016) 0.78
Integromics network meta-analysis on cardiac aging offers robust multi-layer modular signatures and reveals micronome synergism. BMC Genomics (2015) 0.77
Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure. J Cell Mol Med (2015) 0.77
Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunction. JCI Insight (2017) 0.77
A New Pathway for Sympathetic Cardioprotection in Heart Failure. Circ Res (2015) 0.76
Harnessing fetal and adult genetic reprograming for therapy of heart disease. J Nat Sci (2015) 0.76
MicroRNA regulation of autophagy in cardiovascular disease. Front Biosci (Landmark Ed) (2017) 0.76
Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor. Life Sci (2016) 0.76
Epigenetic regulation in heart failure. Curr Opin Cardiol (2016) 0.76
Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball. Curr Cardiol Rep (2017) 0.76
Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention. Biochim Biophys Acta (2017) 0.75
Functions of miRNAs during Mammalian Heart Development. Int J Mol Sci (2016) 0.75
How to be young at heart? miR-22 as a potential therapeutic target to boost autophagy and protect the old myocardium. Ann Transl Med (2017) 0.75
The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application. Int J Mol Sci (2017) 0.75
MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated. World J Biol Chem (2015) 0.75
Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress. Oxid Med Cell Longev (2016) 0.75
The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling. Int J Mol Sci (2017) 0.75
microRNA-144: the 'what' and 'how' of remote ischemic conditioning? Basic Res Cardiol (2014) 0.75
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases. Front Pharmacol (2015) 0.75
Facts and updates about cardiovascular non-coding RNAs in heart failure. ESC Heart Fail (2015) 0.75
Epigenetic regulation in cardiac fibrosis. World J Cardiol (2015) 0.75
Myocardial stress and autophagy: mechanisms and potential therapies. Nat Rev Cardiol (2017) 0.75
microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice. Sci Rep (2016) 0.75
Microarray analysis reveals altered circulating microRNA expression in mice infected with Coxsackievirus B3. Exp Ther Med (2016) 0.75
Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions. Sci Rep (2016) 0.75
RNAi2015 - Ten years of RNAi Oxford. J RNAi Gene Silencing (2015) 0.75
MicroRNA-34a Suppresses Autophagy in Alveolar Type II Epithelial Cells in Acute Lung Injury by Inhibiting FoxO3 Expression. Inflammation (2017) 0.75
New and revisited approaches to preserving the reperfused myocardium. Nat Rev Cardiol (2017) 0.75
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases. Front Med (Lausanne) (2017) 0.75
Genetic background-dependent effects of murine micro RNAs on circadian clock function. PLoS One (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev (2006) 15.20
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell (2007) 14.63
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell (2007) 12.72
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 12.08
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature (2008) 10.73
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med (2007) 8.82
mTOR regulation of autophagy. FEBS Lett (2010) 6.59
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41
Cardiac plasticity. N Engl J Med (2008) 6.29
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A (1991) 5.60
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev (2008) 5.39
A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell (2009) 5.28
Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem (2006) 4.57
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39
miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet (2010) 4.06
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A (2008) 4.00
Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell (2000) 3.44
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest (2004) 3.09
Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation (2008) 2.95
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A (2011) 2.80
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation (2006) 2.55
Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci (1999) 2.45
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res (2009) 2.44
FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem (2009) 2.40
A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol (2011) 2.07
Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol (2010) 1.87
The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med (2003) 1.80
PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol (2010) 1.77
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol (2010) 1.74
Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy (2010) 1.70
Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene (2003) 1.49
Functional significance and morphological characterization of starvation-induced autophagy in the adult heart. Am J Pathol (2009) 1.47
The FoxO family in cardiac function and dysfunction. Annu Rev Physiol (2010) 1.33
Flow cytometric analysis of autophagy in living mammalian cells. Methods Enzymol (2009) 1.28
The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc Res (2011) 1.27
Biogenesis and regulation of cardiovascular microRNAs. Circ Res (2011) 1.23
Mitochondrial turnover in the heart. Biochim Biophys Acta (2010) 1.23
A role for caspase-1 in heart failure. Circ Res (2007) 1.13
FoxO, autophagy, and cardiac remodeling. J Cardiovasc Transl Res (2010) 1.11
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J (2012) 1.05
What causes a broken heart--molecular insights into heart failure. Int Rev Cell Mol Biol (2010) 1.04
MicroRNA-dependent regulation of the microenvironment and the epithelial stromal cell interactions in the mouse mammary gland. Cell Cycle (2011) 0.79
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature (2008) 10.73
Ambra1 regulates autophagy and development of the nervous system. Nature (2007) 6.94
Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension (2012) 6.70
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes (2006) 5.29
miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet (2010) 4.06
MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res (2008) 3.30
What is the role of beta-adrenergic signaling in heart failure? Circ Res (2003) 3.22
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci (2007) 2.78
hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol Cell Biol (2005) 2.69
Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circ Res (2006) 2.66
Pathogenesis and management of hypertension after kidney transplantation. J Hypertens (2011) 2.66
Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. Arterioscler Thromb Vasc Biol (2011) 2.35
Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc (2009) 2.34
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2011) 2.27
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature (2012) 2.27
MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology (2014) 2.23
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation (2008) 2.18
Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation (2012) 2.14
Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes (2007) 2.12
Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res (2005) 2.11
Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res (2005) 2.08
Phytophthora infestans effector AVR3a is essential for virulence and manipulates plant immunity by stabilizing host E3 ligase CMPG1. Proc Natl Acad Sci U S A (2010) 2.07
A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol (2011) 2.07
Analysis of receptor oligomerization by FRAP microscopy. Nat Methods (2009) 2.06
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest (2014) 2.06
Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet (2010) 2.05
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res (2010) 2.04
Cryo-electron microscopy of vitreous sections. EMBO J (2004) 2.03
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med (2005) 2.02
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med (2011) 2.01
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation (2009) 2.01
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology (2003) 2.00
Regulation and function of miRNA-21 in health and disease. RNA Biol (2011) 1.99
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol (2005) 1.99
MicroRNA-24 regulates vascularity after myocardial infarction. Circulation (2011) 1.98
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ Res (2010) 1.96
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol (2011) 1.94
Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol (2012) 1.93
NPP1, a Phytophthora-associated trigger of plant defense in parsley and Arabidopsis. Plant J (2002) 1.93
Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation (2011) 1.91
Phytotoxicity and innate immune responses induced by Nep1-like proteins. Plant Cell (2006) 1.88
Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol (2009) 1.86
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol (2007) 1.85
Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med (2007) 1.83
MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets (2010) 1.82
Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 1.79
Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology (2012) 1.78
Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res (2005) 1.77
Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol (2007) 1.75
Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. J Mol Cell Cardiol (2004) 1.72
Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension (2007) 1.68
Non-coding RNAs in cardiac remodeling and heart failure. Circ Res (2013) 1.66
MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol (2011) 1.65
Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc Res (2006) 1.65
Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res (2002) 1.64
Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol (2007) 1.63
Effect of MyBP-C binding to actin on contractility in heart muscle. J Gen Physiol (2003) 1.62
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res (2007) 1.61